Ireland - English - HPRA (Health Products Regulatory Authority)

martindale pharmaceuticals ltd - phenobarbital sodium - solution for injection - 15 milligram(s)/millilitre - barbiturates and derivatives; phenobarbital

Ireland - English - HPRA (Health Products Regulatory Authority)

martindale pharmaceuticals ltd - phenobarbital sodium - solution for injection - 30 milligram(s)/millilitre - barbiturates and derivatives; phenobarbital

Ireland - English - HPRA (Health Products Regulatory Authority)

martindale pharmaceuticals ltd - phenobarbital sodium - solution for injection - 60 milligram(s)/millilitre - barbiturates and derivatives; phenobarbital

New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - phenobarbital sodium 200 mg/ml - solution for injection - 200 mg/ml - active: phenobarbital sodium 200 mg/ml

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

laboratoires sterop sa-nv - phenobarbital sodium 200 mg/2 ml - solution for injection - 200 mg/2 ml - phenobarbital sodium 100 mg/ml - phenobarbital

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

martindale pharmaceuticals ltd - phenobarbital sodium - solution for injection - 200mg/1ml

Kenya - English - Pharmacy and Poisons Board

tasa pharma ltd kay complex, unit c1-c3 kay complex, mombasa rd, - phenobarbital sodium - solution for injection - 200mg/ml - phenobarbital

United States - English - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - phenobarbital sodium (unii: sw9m9bb5k3) (phenobarbital - unii:yqe403bp4d) - phenobarbital sodium 65 mg in 1 ml - - sedative. sedation is obtainable within an hour, and in adequate dosage, the duration of action is more than six hours. included in the more common conditions in which the sedative action of this class of drugs is desired are anxiety-tension states, hyperthyroidism, essential hypertension, nausea and vomiting of functional origin, motion sickness, acute labyrinthitis, pylorospasm in infants, chorea and cardiac failure. phenobarbital is also a useful adjunct in treatment of hemorrhage from the respiratory or gastrointestinal tract. phenobarbital controls anxiety, decreases muscular activity and lessens nervous excitability in hyperthyroid patients. however, thyrotoxic individuals occasionally react poorly to barbiturates. - hypnotic, for the short-term treatment of insomnia, since it appears to lose its effectiveness for sleep induction and sleep maintenance after 2 weeks (see clinical pharmacology ). -  preanesthetic. - long-term anticonvulsant, (phenobarbital, mephobarbital and metharbital) for the treatme

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

idaman pharma sdn. bhd. - phenobarbital sodium -

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

martindale pharmaceuticals ltd - phenobarbital sodium - solution for injection - 60mg/1ml